Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide.

Publication ,  Journal Article
Clowse, MEB; Harward, L; Criscione-Schreiber, L; Pisetsky, D; Copland, S
Published in: Arthritis Rheum
May 2012

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Arthritis Rheum

DOI

EISSN

1529-0131

Publication Date

May 2012

Volume

64

Issue

5

Start / End Page

1305 / 1310

Location

United States

Related Subject Headings

  • Rheumatic Diseases
  • Primary Ovarian Insufficiency
  • Ovary
  • Immunosuppressive Agents
  • Humans
  • Follicle Stimulating Hormone
  • Female
  • Cyclophosphamide
  • Biomarkers
  • Arthritis & Rheumatology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Clowse, M. E. B., Harward, L., Criscione-Schreiber, L., Pisetsky, D., & Copland, S. (2012). Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide. Arthritis Rheum, 64(5), 1305–1310. https://doi.org/10.1002/art.34431
Clowse, Megan E. B., Lindsey Harward, Lisa Criscione-Schreiber, David Pisetsky, and Susannah Copland. “Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide.Arthritis Rheum 64, no. 5 (May 2012): 1305–10. https://doi.org/10.1002/art.34431.
Clowse MEB, Harward L, Criscione-Schreiber L, Pisetsky D, Copland S. Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide. Arthritis Rheum. 2012 May;64(5):1305–10.
Clowse, Megan E. B., et al. “Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide.Arthritis Rheum, vol. 64, no. 5, May 2012, pp. 1305–10. Pubmed, doi:10.1002/art.34431.
Clowse MEB, Harward L, Criscione-Schreiber L, Pisetsky D, Copland S. Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide. Arthritis Rheum. 2012 May;64(5):1305–1310.
Journal cover image

Published In

Arthritis Rheum

DOI

EISSN

1529-0131

Publication Date

May 2012

Volume

64

Issue

5

Start / End Page

1305 / 1310

Location

United States

Related Subject Headings

  • Rheumatic Diseases
  • Primary Ovarian Insufficiency
  • Ovary
  • Immunosuppressive Agents
  • Humans
  • Follicle Stimulating Hormone
  • Female
  • Cyclophosphamide
  • Biomarkers
  • Arthritis & Rheumatology